# Alamar Biosciences, Inc.: filings

ALMR · Nasdaq · CIK 2104204 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/almr.md) · [Financials](/companies/almr/financials.md) · [Filings](/companies/almr/filings.md) · [Insiders](/companies/almr/insiders.md)

## Reports and events: 13 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 16, 3 12, 8-K 5, 144 4, SCHEDULE 13G 3, 10-Q 2, DRS/A 2, EFFECT 2, S-1/A 2, SCHEDULE 13D 2, 424B4 1, 8-A12B 1, CERT 1, DRS 1, POS AM 1, S-1 1, S-1MEF 1, S-8 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-01 | 16:01 ET | [8-K](/filings/0001193125-26-378360.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-378360 |
| 2026-08-11 | 20:30 ET | [10-Q](/filings/0001193125-26-343003.md) | Quarterly report, period 2026-06-30 | 0001193125-26-343003 |
| 2026-08-10 | 16:10 ET | [8-K](/filings/0001193125-26-342378.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342378 |
| 2026-07-15 | 16:04 ET | [8-K](/filings/0001193125-26-304736.md) | 8.01 Other events | 0001193125-26-304736 |
| 2026-07-07 | 16:55 ET | [SCHEDULE 13D/A](/filings/0001875620-26-000010.md) | Ownership report, active investor, amended | 0001875620-26-000010 |
| 2026-05-08 | 08:30 ET | [10-Q](/filings/0001193125-26-213424.md) | Quarterly report, period 2026-03-31 | 0001193125-26-213424 |
| 2026-05-08 | 08:05 ET | [8-K](/filings/0001193125-26-213379.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-213379 |
| 2026-04-23 | 16:24 ET | [SCHEDULE 13D](/filings/0001193125-26-173780.md) | Ownership report, active investor | 0001193125-26-173780 |
| 2026-04-23 | 13:57 ET | [SCHEDULE 13D](/filings/0001875620-26-000007.md) | Ownership report, active investor | 0001875620-26-000007 |
| 2026-04-20 | 16:02 ET | [8-K](/filings/0001193125-26-163921.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-163921 |
| 2026-04-16 | 09:25 ET | [S-1/A](/filings/0001193125-26-158122.md) | Registration statement, amended | 0001193125-26-158122 |
| 2026-04-13 | 06:05 ET | [S-1/A](/filings/0001193125-26-151891.md) | Registration statement, amended | 0001193125-26-151891 |
| 2026-03-27 | 16:12 ET | [S-1](/filings/0001193125-26-129039.md) | Registration statement | 0001193125-26-129039 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:10 ET. No prices; not investment advice.